Fund size | GBP 197 m |
Total expense ratio | 0.18% p.a. |
Replication | Physical (Full replication) |
Legal structure | ETF |
Strategy risk | Long-only |
Fund currency | EUR |
Currency risk | Currency unhedged |
Volatility 1 year (in GBP) | 11.29% |
Inception/ Listing Date | 20 September 2022 |
Distribution policy | Accumulating |
Distribution frequency | - |
Fund domicile | Ireland |
Fund Provider | Amundi ETF |
Fund Structure | Company With Variable Capital (SICAV) |
UCITS compliance | Yes |
Administrator | HSBC Securities Services (Ireland) |
Investment Advisor | |
Custodian Bank | HSBC Bank plc |
Revision Company | - |
Fiscal Year End | 31 December |
Swiss representative | NO |
Swiss paying agent | NO |
Germany | 30% tax rebate |
Switzerland | No ESTV Reporting |
Austria | Non-Tax Reporting Fund |
UK | UK Reporting |
Indextype | Total return index |
Swap counterparty | - |
Collateral manager | |
Securities lending | No |
Securities lending counterparty |
UnitedHealth Group | 8.90% |
Eli Lilly & Co | 8.67% |
Novo Nordisk | 6.41% |
AbbVie | 5.90% |
Merck & Co | 3.61% |
Novartis | 3.57% |
Abbott Laboratories | 3.49% |
AstraZeneca | 3.47% |
Thermo Fisher Scientific | 3.05% |
Roche Holding | 2.97% |
United States | 66.64% |
Switzerland | 7.92% |
United Kingdom | 5.29% |
Japan | 4.99% |
Other | 15.16% |
Health Care | 92.92% |
Consumer Discretionary | 0.46% |
Other | 6.62% |
YTD | +3.52% |
1 month | -2.18% |
3 months | +1.51% |
6 months | +3.98% |
1 year | +4.56% |
3 years | - |
5 years | - |
Since inception (MAX) | +7.67% |
2023 | +0.11% |
2022 | - |
2021 | - |
2020 | - |
Volatility 1 year | 11.29% |
Volatility 3 years | - |
Volatility 5 years | - |
Return per risk 1 year | 0.40 |
Return per risk 3 years | - |
Return per risk 5 years | - |
Maximum drawdown 1 year | -9.57% |
Maximum drawdown 3 years | - |
Maximum drawdown 5 years | - |
Maximum drawdown since inception | -11.61% |
Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
---|---|---|---|---|---|
gettex | EUR | WELS | - - | - - | - |
XETRA | USD | WEL9 | WEL9 GY IWEL9 | WELSGUSD.DE IWEL9USDINAV=SOLA | BNP Paribas Arbitrage |
XETRA | EUR | WELS | WELS GY IWELS | WELSG.DE IWELSEURINAV=SOLA | BNP Paribas Arbitrage |
Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
---|---|---|---|---|
iShares Healthcare Innovation UCITS ETF | 951 | 0.40% p.a. | Accumulating | Sampling |
iShares Ageing Population UCITS ETF | 434 | 0.40% p.a. | Accumulating | Sampling |
Xtrackers MSCI Global SDG 3 Good Health UCITS ETF 1C | 136 | 0.35% p.a. | Accumulating | Full replication |
iShares MSCI World Health Care Sector ESG UCITS ETF USD (Acc) | 86 | 0.18% p.a. | Accumulating | Sampling |
VanEck Genomics and Healthcare Innovators UCITS ETF A | 6 | 0.35% p.a. | Accumulating | Full replication |